Serum CA 125 in acute pelvic inflammatory disease

J Paavonen, A Miettinen, PK Heinonen… - … Journal of Obstetrics …, 1989 - Wiley Online Library
Serum levels of CA 125 and other selected tumour markers were measured in 31 patients
with proven pelvic inflammatory disease (PID). Ten (32%) of the patients had elevated CA …

The role of tumor markers in gynecologic oncology

G Olt, A Berchuck, RC BAST JR - Obstetrical & gynecological …, 1990 - journals.lww.com
The epithelial cells that line the female genital tract give rise to most gynecologic cancers.
Epithelial cancers of the vulva, vagina, and cervix often are detected at an early stage …

Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs

S Nishimura, H Tsuda, K Ito, T Jobo, N Yaegashi… - Human pathology, 2007 - Elsevier
Previously, we reported that ABCF2 protein expression is higher in clear cell than serous
histotype of ovarian adenocarcinomas and that its expression correlates with …

Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites

M Ba, H Long, X Zhang, Y Tang, Y Wu, F Yu… - Journal of cancer …, 2014 - Springer
Background and objectives Treatment for malignant ascites in advanced ovarian cancer
(OC) patients remains controversial. The objective of this study was to investigate the …

Use of CA-125 response to predict survival parameters of patients with advanced ovarian carcinoma

IG Ron, M Inbar, I Gelernter, O Lewysohn… - Acta obstetricia et …, 1994 - Taylor & Francis
The prognostic value of serum CA-125 levels both before chemotherapy and after each
cycle of one or two courses was assessed in 48 patients with advanced ovarian …

CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma

IB Vergote, VM Abeler, OP Børmer, T Stigbrand… - Tumor Biology, 1992 - karger.com
Placental alkaline phosphatase (PLAP) was measured by an immunoradiometric assay
using the monoclonal antibody C2 (PLAP-C2). Serum samples of 135 patients with epithelial …

A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer

AC Rossi, G Di Vagno, G Cormio, A Cazzolla… - Archives of Gynecology …, 2004 - Springer
Introduction. The aim of our study was to investigate preoperative serum CA 125 as a
prognostic factor in patients with ovarian carcinoma. Methods. A retrospective analysis was …

Serum CA125 regression in epithelial ovarian cancer: correlation with reassessment findings and survival

RE Buller, ML Berman, JD Bloss, A Manetta… - Gynecologic …, 1992 - Elsevier
Findings at reassessment laparotomy and disease-free survival are reported for a group of
patients with advanced-stage epithelial ovarian cancer who have had a complete clinical …

Tumour markers

U Menon, J Dilley - 2018 - discovery.ucl.ac.uk
A tumor marker is defined as a molecule or substance produced by or in response to
neoplastic proliferation, which enters the circulation in detectable amounts. It indicates the …

The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract

REN Van Rijswijk, G Tognon, CW Burger… - International Journal of …, 1994 - ijgc.bmj.com
The effect of chemotherapy on the different components of uterine and ovarian
carcinosarcoma is largely unknown. This report describes six patients with advanced …